Pharvaris N.V. Share Price
NASDAQ: PHVSPharvaris N.V. Stock Performance
Pharvaris N.V. Share Price Today
As of 9 October 2026, Pharvaris N.V.'s share price is $31.45. The stock opened at $31.21, compared to its previous close of $31.13. During today's trading session, Pharvaris N.V.'s share price traded between $31.21 and $31.89, with an average price of $31.55. Over the past 52 weeks, the stock has recorded a high of $43.03 and a low of $20.92. In terms of performance, Pharvaris N.V.'s share price has risen by 1.34% over the last six months and is up 41.60% on a year-on-year basis.
Pharvaris N.V. Share Price Chart
Pharvaris N.V. Annual Profit & Loss
All figures in USD
About Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
Pharvaris N.V. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $31.57 | $31.33 | -1.43% |
Sep 2026 | $34.02 | $31.79 | -14.16% |
Aug 2026 | $32.34 | $37.03 | +13.59% |
Jul 2026 | $34.20 | $32.60 | -5.51% |
Jun 2026 | $29.47 | $34.50 | +14.39% |
May 2026 | $30.69 | $30.16 | -2.82% |
Apr 2026 | $27.78 | $31.04 | +9.92% |
Mar 2026 | $28.36 | $28.23 | -0.49% |
Feb 2026 | $27.89 | $28.38 | +4.84% |
Jan 2026 | $27.70 | $27.07 | -2.45% |
Dec 2025 | $28.39 | $27.75 | -1.89% |
Nov 2025 | $22.63 | $28.28 | +27.33% |